india-conf-6th-2015-headerv2

ADAMAS Consulting’s APAC Director, Shehnaz Vakharia, will be taking part in a panel discussion on “Quality and Safety Considerations in Clinical Development: Identifying ideal clinical sites and strategizing patient recruitment and clinical sites management in India to develop appropriate clinical studies”


The panel discussion will be taking place at Virtue Insight’s 6th Annual Clinical Trials Summit and the event will provide an excellent opportunity for clinical researchers to interact; review the current situation in India as well as the rest of the world; present current updates/data and findings/papers; share knowledge; hear directly from the experts.

Virtue Insight’s 6th Annual Clinical Trials Summit will be taking place on the 28th & 29th May at the Kohinoor Continental Hotel, Mumbai. It will examine the current issues faced in clinical trials operations, addressing the risks, timeline and budget stipulations, while effectively tackling key challenges in overcoming trials agreement and site contract arbitration problems. The summit will discuss the operational element of trial site management, strategic partnership with CROs and SMOs, patient, talent &investigators management in order to improve & optimize the overall drug development effectiveness and ROI.

We hope you can attend and we look forward to meeting you.

The ADAMAS Corporate Brochure 2016

 

Brochure – Please download the ADAMAS brochure describing our QA services and contact details.

×
Regulatory Environment

 

The development of medicines is the most regulated industry in the world, and compliance at each stage of the research and development process, as well as after licensing, is critical to ensuring high quality and safe medicines reach patients in a timely manner.

adamas-quality-assurance-services

 

ADAMAS’s consultants have expertise across the G’X’Ps in pre-clinical, clinical and post-licensing areas. They have worked across many different therapeutic areas and product types including oncology, vaccines, biologics, medical devices and gene therapy. As a company we have developed close partnerships with our clients to support them in their development programmes and post-licensing activities, and to guide them successfully through their worldwide regulatory inspections.

 

×
How to be a Clinical Auditor

 

‘So you want to be a Clinical Auditor?’, an article written by CEO Dr. Patricia Fitzgerald.

×
Benchmarking Data

 

Please download our benchmarking data sheet, to see how these data compare with your own performance. To discuss a more detailed report, or analysis of a data subset, please get in touch.

×
Is your QMS compliant?

 

Is your QMS compliant to the upcoming ICH E6 Addendum? Download our 5-point checklist

×
ICH (E6) R2 Addendum - Step 4

 

Please enter your details to complete the download.

×

×